Safety of tedizolid as suppressive antimicrobial therapy for patients with complex implant-associated bone and joint infection due to multidrug-resistant Gram-positive pathogens: results from the TediSAT cohort study
- 31th European Society of Clinical Microbiology and Infectious Diseases (ECCMID)
- du 09/07/2021 au 12/07/2021
- Virtual Event
Implementation of a phage therapy center in France dedicated to complex bone and joint infection: 4-year experience of multidisciplinarity and multistep interactions
Impact on the gut microbiota of intensive and prolonged antimicrobial therapy in patients with bone and joint infection
Isolation and characterization of a novel Jumbo phage active against the emerging ST307 carbapenemase-producing K. pneumoniae clone
Targeting coagulase negative staphylococci causing prosthetic infections with bacteriophages: can we use polyvalent anti Staphylococcus phages ?